TRCT
PPBT

Tower Research Capital (TRC)’s Purple Biotech PPBT Stock Holding History

Tower Research Capital (TRC)’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23
Closed -$1.06K – 5653
2024
Q4 		$1.06K Sell
23
-2
-8% -$77 ﹤0.01% 5102
2024
Q3 		$1.42K Buy
+25
New +$1.89K ﹤0.01% 5158
2022
Q1 		– Hold
0
– – – 6454
2021
Q4 		– Hold
0
– – – 6469
2016
Q4 		– Hold
0
– -$1K – 4275
2016
Q3 		– Hold
0
– – – 3346
2016
Q2 		– Hold
0
– – – 3941
2016
Q1 		– Hold
0
– – – 3142
2015
Q4 		– Hold
0
– – – 4929

Other funds holding PPBT

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Tower Research Capital (TRC)'s PPBT Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Purple Biotech (PPBT) in Q1 2025, closing a stake of 23 shares — an estimated $1.06K sold.

Tower Research Capital (TRC) first reported a position in PPBT in Q3 2024 and held it in 2 quarters. The position peaked at $1.42K in Q3 2024. 9 funds tracked by Wall St. Rank hold PPBT as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Purple Biotech position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 23 Purple Biotech shares in Q1 2025, an estimated $1.06K.
  • Tower Research Capital (TRC) first reported a position in Purple Biotech in Q3 2024 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Purple Biotech position peaked at $1.42K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.